SYNICEM Bone Cement UK Launch

About Biocomposites

Biocomposites is a commercial-stage, privately-held medical device company with a 30-year legacy in calcium-based biomaterials. The company's product portfolio, led by the STIMULAN antibiotic carrier and SYNICEM bone cements/spacers, targets the significant clinical challenges of osteomyelitis, periprosthetic joint infections, and bone trauma. Recent strategic moves, including MDR certification in Europe, expansion into the US and Canadian markets, and a planned UK launch to address an NHS supply crisis, position the company for accelerated growth in the global orthobiologics and bone infection management markets.

Therapeutic Areas